Regulating Medicines in Europe: Competition, Expertise and Public Health Contributor(s): Abraham, John (Author), Lewis, Graham (Author) |
|
ISBN: 0415208785 ISBN-13: 9780415208789 Publisher: Routledge OUR PRICE: $28.45 Product Type: Paperback - Other Formats Published: September 2000 Annotation: Drawing on detailed research undertaken over the last four years in Brussels, Germany, the Netherlands and the UK, "Regulating Medicines in Europe" presents a critical appraisal of medicines regulation policy and exposes the influence of the pharmaceutical industry in the acceleration of drug approvals. |
Additional Information |
BISAC Categories: - Medical | Health Policy - Medical | Public Health - Medical | Health Care Delivery |
Dewey: 353.998 |
LCCN: 00028615 |
Physical Information: 0.54" H x 5.5" W x 8.5" (0.66 lbs) 256 pages |
Descriptions, Reviews, Etc. |
Publisher Description: This Book explains and investigates how medicines are controlled in Europe, especially the EU. Based on penetrating documentary and interview research with the pharmaceutical industry, regulators and consumer organisations, it provides the first major critical examination of the new Europeanised systems of medicine regulation. The authors argue that the drive to produce and approve more drugs more quickly for a single European market dominates other considerations, such as improvements in democratic accountability, the independence of regulators and scientific expertise from commercial interests, and drug safety testing and surveillance |